Growth Metrics

TELA Bio (TELA) Free Cash Flow (2018 - 2026)

TELA Bio has reported Free Cash Flow over the past 8 years, most recently at -$5.0 million for Q4 2025.

  • For Q4 2025, Free Cash Flow rose 36.36% year-over-year to -$5.0 million; the TTM value through Dec 2025 reached -$28.7 million, up 32.68%, while the annual FY2025 figure was -$28.7 million, 32.68% up from the prior year.
  • Free Cash Flow for Q4 2025 was -$5.0 million at TELA Bio, up from -$5.9 million in the prior quarter.
  • Over five years, Free Cash Flow peaked at -$5.0 million in Q4 2025 and troughed at -$14.7 million in Q1 2024.
  • A 5-year average of -$9.2 million and a median of -$9.3 million in 2021 define the central range for Free Cash Flow.
  • Biggest five-year swings in Free Cash Flow: plummeted 108.69% in 2022 and later soared 36.36% in 2025.
  • Year by year, Free Cash Flow stood at -$9.4 million in 2021, then decreased by 16.63% to -$11.0 million in 2022, then fell by 2.49% to -$11.3 million in 2023, then soared by 30.75% to -$7.8 million in 2024, then soared by 36.36% to -$5.0 million in 2025.
  • Business Quant data shows Free Cash Flow for TELA at -$5.0 million in Q4 2025, -$5.9 million in Q3 2025, and -$8.0 million in Q2 2025.